AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in AN2 Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −13 vs. Q2 2024
- Shares held
- 13.5M
- −5.60M (−29.3%) vs. Q2 2024
- Total value
- $14.5M
- −$26.6M (−64.8%) vs. Q2 2024
- New holders
- 9
- 7 more added
- Sold out
- 22
- 7 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 5,749,432 | $6.15M | 3.62% | +5,749,432 | New |
| Ra Capital Management, L.P. | 1,999,997 | $2.14M | 0.02% | −3,551,298−64.0% | Reduced |
| TCG Crossover Management, LLC | 1,555,118 | $1.66M | 0.14% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,041,527 | $1.11M | 0.00% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 445,783 | $477.0K | 0.21% | +445,783 | New |
| Renaissance Technologies LLC | 423,800 | $453.5K | 0.00% | +409,500+2,863.6% | Added |
| Millennium Management LLC | 397,925 | $425.8K | 0.00% | −128,427−24.4% | Reduced |
| Adage Capital Partners GP, L.L.C. | 312,615 | $334.5K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 301,176 | $322.3K | 0.00% | +301,176 | New |
| Geode Capital Management, LLC | 220,162 | $235.6K | 0.00% | +39,239+21.7% | Added |
| Bridgeway Capital Management, LLC | 197,000 | $210.8K | 0.00% | +92,708+88.9% | Added |
| Two Sigma Investments, LP | 177,840 | $190.3K | 0.00% | +45,752+34.6% | Added |
| Two Sigma Advisers, LP | 120,900 | $129.4K | 0.00% | −13,800−10.2% | Reduced |
| Aldebaran Capital, LLC | 100,500 | $107.5K | 0.10% | +100,500 | New |
| Jacobs Levy Equity Management, Inc | 79,359 | $84.9K | 0.00% | +79,359 | New |
| Schonfeld Strategic Advisors LLC | 66,100 | $70.7K | 0.00% | +44,326+203.6% | Added |
| Marquette Asset Management, LLC | 64,503 | $69.0K | 0.01% | +64,503 | New |
| State Street Corp | 60,302 | $64.5K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 42,335 | $45.0K | 0.00% | −44,613−51.3% | Reduced |
| Northern Trust Corp | 32,595 | $34.9K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 28,667 | $30.7K | 0.00% | 00.0% | Unchanged |
| Integrated Wealth Concepts LLC | 25,000 | $26.8K | 0.00% | +25,000 | New |
| XTX Topco Ltd | 23,659 | $25.3K | 0.00% | +23,659 | New |
| Private Advisor Group, LLC | 22,500 | $24.1K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 16,210 | $17.3K | 0.00% | +574+3.7% | Added |
| Tower Research Capital LLC (TRC) | 4,256 | $4.55K | 0.00% | −1,150−21.3% | Reduced |
| Federated Hermes, Inc. | 3,006 | $3.22K | 0.00% | +2,089+227.8% | Added |
| Morgan Stanley | 303 | $324 | 0.00% | −17,158−98.3% | Reduced |
| Advisor Group Holdings, Inc. | 300 | $321 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 300 | $321 | 0.00% | +300 | New |
| JPMorgan Chase & Co | 54 | $58 | 0.00% | −966−94.7% | Reduced |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −3,220,263−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −2,088,889−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,553,829−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −1,221,051−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −224,185−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −219,331−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −98,278−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −97,063−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −96,111−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −92,406−100.0% | Sold out |
| RMB Capital Management, LLC | 0 | $0 | 0.00% | −45,942−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −38,918−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −37,887−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −35,366−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −31,245−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −25,150−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −17,483−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −12,825−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,186−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −2,812−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |